Institutional investors purchased a net $15.5 million shares of EXAS during the quarter ended June 2016 and now own 90.06% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
D. E. SHAW & CO. LP Bought 781.5 Thousand shares of Exact Sciences Corp
EAGLE ASSET MANAGEMENT, INC. Bought 730.2 Thousand shares of Exact Sciences Corp
FOX RUN MANAGEMENT LLC Bought 29.2 Thousand shares of Exact Sciences Corp